In a sea of digital health apps and AI diagnostics, Approxima Medical is doing something radically old-school: they're building hardware to fix a broken heart—literally. With a team of just 18 and $9.3M in funding, they are targeting a multi-billion dollar market that has been historically underserved by big medtech.

"Approxima isn't trying to be the next big thing in digital health; they're trying to be the next essential thing in cardiac surgery."

The tech stack reveals a utilitarian approach. Using jQuery, Bootstrap, and WooCommerce on their site suggests a focus on function over form—a placeholder until the device is ready for prime time. It’s a stark contrast to the flashy, consumer-facing health startups that dominate headlines. This is infrastructure, not an app.

• Surgical Innovation: Developing a novel treatment specifically for Tricuspid Valve Regurgitation (TVR).
• Lean Operations: Achieving $4.7M in revenue with only 18 employees—a high revenue-per-employee ratio.
• Funding Stability: $9.3M raised indicates strong backing from early-stage medical VCs.
• Niche Focus: Avoiding the crowded mitral/aortic space to dominate a specific, high-need vertical.